April 8, 2013
Amakem NV, a kinase platform company focusing on ophthalmology, today announces it has sponsored a new Chair of Ophthalmology Translational Research at the
Catholic University Leuven
The Chair has been established by the University and Amakem to drive further translational research into the prevention of diseases leading to impaired vision or blindness with a special emphasis on glaucoma. It will be held by Professor
, head of the glaucoma clinic of the Ophthalmology Department at the University Hospital in Leuven (UZLeuven). Professor Stalmans also runs an ophthalmology laboratory at KU Leuven and is a member of Amakem's Clinical Advisory Board.
Professor Stalmans said: "Amakem is a relatively young company to sponsor a Chair at a leading University and it is a measure of the maturity of their approach. As a member of the Amakem Clinical Advisory Board, I have had the opportunity to work closely with them as they have advanced AMA0076 into the clinic as a highly promising new treatment for glaucoma and ocular hypertension. I am grateful for the opportunity presented by the Chair to advance work into the science underlying glaucoma and other diseases and look forward to this work being translated into new medicines."
The KU Leuven Chair sponsorship is intended to further fundamental research and the Chair holder is appointed by the Rector of the University on the recommendation of the Dean of the relevant faculty. The Chair holder can use the gift to fund teaching or research. Amakem has initially committed to funding the Chair for three years.
, CEO of Amakem, said: "It is with great pride that we make this announcement. We have already established a very strong relationship with KU Leuven and this sponsorship will serve to build on that and provide valuable funding to research aimed at improving treatment for patients with sight threatening conditions. We look forward to new insight being generated, particularly improved understanding of the causes and potential treatment of glaucoma."
In healthy eyes, aqueous humor flows through the eye and exits, primarily via the trabecular meshwork, to maintain the appropriate intraocular pressure. In glaucoma, increased pressure leads to damage of the optic nerve resulting in vision loss and ultimately blindness. It is expected that Prof. Stalmans will focus part of her work as Chair of Ophthalmology Translational Research on strategies to improve eye health by restoring the function of the trabecular meshwork.